AbClon said partner Henlius expanded clinical programs for HER2 antibody AC101 to nine, adding a Phase 2 colorectal cancer ...
XYone Therapeutics, Inc. ("XYone"), a clinical-stage biotechnology company, announced that the first patient has been dosed in the first-in-human Phase 1b/2 clinical trial of XYA02(also known as ...
AstraZeneca ( AZN) has agreed to make a $2 billion strategic equity investment in Summit Therapeutics ( SMMT) while launching a clinical collaboration aimed at advancing new cancer treatment ...
The US will exempt select Indian specialty drugs and their ingredients from a new 100% pharma tariff. Here’s what products ...
Summit Therapeutics (SMMT) shares rose early Tuesday after British drugmaker AstraZeneca (AZN) agreed to invest $2 billion in ...
5hon MSN
Summit Therapeutics soars nearly 20% after AstraZeneca bets $2 billion on cancer drug Ivonescimab
Shares of Summit Therapeutics Inc. (NASDAQ: SMMT) surged about 20% premarket on Tuesday after AstraZeneca Plc (NYSE: AZN) ...
AstraZeneca agreed to invest $2 billion in Summit Therapeutics, handing its seal of approval to a bispecific cancer drug ...
AstraZeneca invests $2b in Summit Therapeutics to boost cancer drug development and explore new treatment combinations.
The equity investment comes alongside a deal to test Summit’s ivonescimab alongside potentially many AstraZeneca drugs — but ...
Generic medicines remain outside the Section 232 pharmaceutical tariff regime, while the latest US Commerce Department notice also creates zero-duty treatment for covered drugs used solely in clinical ...
AstraZeneca (AZN) has made a strategic equity investment of $2 billion in anti-cancer drug developer Summit Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results